Literature DB >> 10210988

Varicella: to vaccinate or not to vaccinate?

A Gershon1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 10210988      PMCID： PMC1717764          DOI： 10.1136/adc.79.6.470

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  45 in total

1.  Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.

Authors:  Y Asano; S Suga; T Yoshikawa; I Kobayashi; T Yazaki; M Shibata; K Tsuzuki; S Ito
Journal:  Pediatrics       Date:  1994-10       Impact factor: 7.124

2.  Cisapride decreases prolonged episodes of reflux in infants.

Authors:  Y Vandenplas; C de Roy; L Sacre
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-01       Impact factor: 2.839

Review 3.  Varicella-zoster virus: prospects for control.

Authors:  A A Gershon
Journal:  Adv Pediatr Infect Dis       Date:  1995

Review 4.  A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN).

Authors:  Y Vandenplas; A Ashkenazi; D Belli; N Boige; J Bouquet; S Cadranel; J P Cezard; S Cucchiara; C Dupont; K Geboes
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

5.  The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.

Authors:  I Hardy; A A Gershon; S P Steinberg; P LaRussa
Journal:  N Engl J Med       Date:  1991-11-28       Impact factor: 91.245

6.  Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy.

Authors:  K Terada; S Kawano; K Yoshihiro; T Morita
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

7.  New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up.

Authors:  A Malfroot; I Dab
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

8.  [Evaluation of the effectiveness of cisapride in the treatment of gastroesophageal reflux].

Authors:  G Iacono; A Carroccio; G Montalto; F Cavataio; D Lorello; M Soresi; I Kazmierska; V Balsamo
Journal:  Minerva Pediatr       Date:  1992-12       Impact factor: 1.312

9.  [Intestinal dysmotility-pseudo-obstruction].

Authors:  J M Gil Vernet; J M Casasa; J Boix Ochoa; A Salas; J Broto; C Marhuenda
Journal:  Cir Pediatr       Date:  1992-04

10.  Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction.

Authors:  P E Hyman; C Di Lorenzo; L McAdams; A F Flores; T Tomomasa; T Q Garvey
Journal:  Am J Gastroenterol       Date:  1993-06       Impact factor: 10.864
View more
  3 in total

1.  Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group.

Authors:  N J Webb; M M Fitzpatrick; D A Hughes; T J Brocklebank; B A Judd; M A Lewis; R J Postlethwaite; P A Smith; G Corbitt
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

2.  A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus.

Authors:  Chad J Roy; A Paige Adams; Eryu Wang; Grace Leal; Robert L Seymour; Satheesh K Sivasubramani; William Mega; Ilya Frolov; Peter J Didier; Scott C Weaver
Journal:  Vaccine       Date:  2013-01-16       Impact factor: 3.641

3.  Chickenpox infection after renal transplantation.

Authors:  Anupma Kaul; Raj K Sharma; Dharmendra Bhadhuria; Amit Gupta; Narayan Prasad
Journal:  Clin Kidney J       Date:  2012-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.